[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Opko Health Inc (OPK)

Opko Health Inc (OPK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,057,129
  • Shares Outstanding, K 755,092
  • Annual Sales, $ 606,880 K
  • Annual Income, $ -225,680 K
  • EBIT $ -24 M
  • EBITDA $ 73 M
  • 60-Month Beta 1.49
  • Price/Sales 1.82
  • Price/Cash Flow N/A
  • Price/Book 0.92

Options Overview Details

View History
  • Implied Volatility 307.13% (+143.08%)
  • Historical Volatility 49.29%
  • IV Percentile 94%
  • IV Rank 38.42%
  • IV High 713.69% on 03/11/26
  • IV Low 53.43% on 08/22/25
  • Expected Move (DTE 16) 0.0425 (3.01%)
  • Put/Call Vol Ratio 0.01
  • Today's Volume 720
  • Volume Avg (30-Day) 375
  • Put/Call OI Ratio 0.05
  • Today's Open Interest 33,883
  • Open Int (30-Day) 31,994
  • Expected Range 1.3675 to 1.4525

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.08
  • Number of Estimates 5
  • High Estimate $-0.07
  • Low Estimate $-0.08
  • Prior Year $-0.19
  • Growth Rate Est. (year over year) +57.89%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.0750 +28.84%
on 05/15/26
1.5000 -7.67%
on 05/29/26
+0.2850 (+25.91%)
since 05/01/26
3-Month
0.9769 +41.78%
on 04/29/26
1.5000 -7.67%
on 05/29/26
+0.1450 (+11.69%)
since 03/02/26
52-Week
0.9769 +41.78%
on 04/29/26
1.6000 -13.44%
on 10/06/25
+0.0050 (+0.36%)
since 06/02/25

Most Recent Stories

More News
OPKO Health’s ModeX Therapeutics Will Present Data Demonstrating In Vivo CAR-T Cell Generation and Deep B-Cell Depletion in Preclinical Studies

Multispecific antibody conjugated LNP/mRNA platform enables in vivo T-cell engineering and systemic B-cell depletion in animal models  Data will be presented at the American Society of Gene & Cell...

OPK : 1.3850 (-1.07%)
OPKO Health Expands Nicoya Agreement to Support RAYALDEE® Commercialization in Greater China

MIAMI, April 30, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) (OPKO) today announced that its subsidiary EirGen Pharma Limited (EirGen) has entered into an amendment to its agreement with...

OPK : 1.3850 (-1.07%)
BioReference® Launches BioReference Direct™, Expanding Access to Consumer-Initiated Diagnostic Testing Through a Fully Integrated Digital Platform

ELMWOOD PARK, N.J., April 30, 2026 (GLOBE NEWSWIRE) -- BioReference® Health LLC, an OPKO Health, Inc. company and a trusted provider of diagnostic testing in the United States, today announced the launch...

OPK : 1.3850 (-1.07%)
OPKO Health: Q1 Earnings Snapshot

OPKO Health: Q1 Earnings Snapshot

OPK : 1.3850 (-1.07%)
OPKO Health Reports First Quarter 2026 Business Highlights and Financial Results

MIAMI, April 28, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) (OPKO) reports business highlights and financial results for the three months ended March 31, 2026. Highlights from the...

OPK : 1.3850 (-1.07%)
OPKO Health's Diagnostics Dependency Meets Growing Questions About Lab Volume Trajectory

Barchart Research What to Expect from OPK Earnings OPK Generated April 27, 2026 Current Price $1.2000 EPS Estimate $$-0.07 Consensus Rating Moderate Buy Average Move 4.81% OPKO Health's Diagnostics Dependency...

OPK : 1.3850 (-1.07%)
OPKO Health’s ModeX Therapeutics Begins Clinical Trial of Tetraspecific Antibody for Treatment of B-cell Lymphomas

Patients dosed in Phase 1 safety and tolerability study of MDX2003, a novel T-cell engager designed to optimize killing of lymphomas Preclinical studies presented at 2025 American Society of Hematology...

OPK : 1.3850 (-1.07%)
OPKO Health to Report First Quarter 2026 Financial Results on April 28, 2026

MIAMI, April 21, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three months ended March 31, 2026 after the close of the U.S. financial...

OPK : 1.3850 (-1.07%)
OPKO Health’s ModeX Therapeutics Initiates Clinical Trial of MDX2301 for the Prevention of COVID-19

WESTON, Mass., April 08, 2026 (GLOBE NEWSWIRE) -- ModeX Therapeutics Inc., an OPKO Health company (NASDAQ: OPK), today announced that the first participants have been dosed in a Phase 1 clinical trial...

OPK : 1.3850 (-1.07%)
OPKO Health to Participate in the Jefferies Biotech on the Beach Summit

MIAMI, Feb. 27, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the Jefferies Biotech on the Beach Summit, being held March 10-11,...

OPK : 1.3850 (-1.07%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and...

See More

Key Turning Points

3rd Resistance Point 1.5150
2nd Resistance Point 1.4800
1st Resistance Point 1.4400
Last Price 1.3850
1st Support Level 1.3650
2nd Support Level 1.3300
3rd Support Level 1.2900

See More

52-Week High 1.6000
Last Price 1.3850
Fibonacci 61.8% 1.3620
Fibonacci 50% 1.2885
Fibonacci 38.2% 1.2149
52-Week Low 0.9769

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.